New therapeutic avenue in the fight against chronic liver disease

by Ulsan National Institute of Science and TechnologySchematic image showing the ETP expression and survival rate in liver tissue from HCC patients. Credit: UNISTAn international team of research

Updated on: April 10,2024

New therapeutic avenue in the fight against chronic liver disease

by Ulsan National Institute of Science and TechnologySchematic image showing the ETP expression and survival rate in liver tissue from HCC patients. Credit: UNISTAn international team of research

Updated on:April 10,2024

Researchers block two cancer cell signaling pathways and slow tumor growth

by Case Western Reserve UniversityBlocking two molecular pathways that send signals inside cancer cells could stave off esophageal adenocarcinoma (EAC), the most common esophageal malignancy in t

Updated on: June 01,2024

Researchers block two cancer cell signaling pathways and slow tumor growth

by Case Western Reserve UniversityBlocking two molecular pathways that send signals inside cancer cells could stave off esophageal adenocarcinoma (EAC), the most common esophageal malignancy in t

Updated on:June 01,2024

Living alone doesn't have to mean being lonely, says study

by Sebastian Hollstein, Friedrich-Schiller-Universität JenaLiving alone does not necessarily mean isolation and loneliness, according to a recent study by the University of Jena. Credit: Jens Meyer/Un

Updated on: May 21,2024

Living alone doesn't have to mean being lonely, says study

by Sebastian Hollstein, Friedrich-Schiller-Universität JenaLiving alone does not necessarily mean isolation and loneliness, according to a recent study by the University of Jena. Credit: Jens Meyer/Un

Updated on:May 21,2024

Research uncovers potential pathway for breast cancer treatment

by Elizabeth Chapin,University of KentuckyYadi Wu, Ph.D., University of Kentucky Markey Cancer Center. Credit: Ben Corwin/University of KentuckyA recent University of Kentucky Markey Cancer Cent

Updated on: March 20,2024

Research uncovers potential pathway for breast cancer treatment

by Elizabeth Chapin,University of KentuckyYadi Wu, Ph.D., University of Kentucky Markey Cancer Center. Credit: Ben Corwin/University of KentuckyA recent University of Kentucky Markey Cancer Cent

Updated on:March 20,2024

Perspective on management of LDCT findings on low-dose computed tomography examinations for lung cancer screening

by International Association for the Study of Lung CancerTop 10 global causes of deaths,2016. Credit:Journal of Thoracic Oncology(2023). DOI: 10.1016/j.jtho.2023.11.013Annual low-dos

Updated on: December 28,2023

Perspective on management of LDCT findings on low-dose computed tomography examinations for lung cancer screening

by International Association for the Study of Lung CancerTop 10 global causes of deaths,2016. Credit:Journal of Thoracic Oncology(2023). DOI: 10.1016/j.jtho.2023.11.013Annual low-dos

Updated on:December 28,2023

Researchers pinpoint tumor-related protein, slow progression of cancers

by University of Nebraska-LincolnThe University of Nebraska-Lincoln's Paul Black (left) and Concetta DiRusso have co-authored a new study that could improve the treatment of malignant tumors.

Updated on: June 11,2024

Researchers pinpoint tumor-related protein, slow progression of cancers

by University of Nebraska-LincolnThe University of Nebraska-Lincoln's Paul Black (left) and Concetta DiRusso have co-authored a new study that could improve the treatment of malignant tumors.

Updated on:June 11,2024

Researchers compare tumor characteristics, survival outcome of different bile duct cancers

byBoston University School of MedicineCredit: CC0 Public DomainCholangiocarcinoma (CCA) or bile duct cancer, is a rare, aggressive liver cancer with a poor prognosis, which occurs mostly in peop

Updated on: September 30,2024

Researchers compare tumor characteristics, survival outcome of different bile duct cancers

byBoston University School of MedicineCredit: CC0 Public DomainCholangiocarcinoma (CCA) or bile duct cancer, is a rare, aggressive liver cancer with a poor prognosis, which occurs mostly in peop

Updated on:September 30,2024

Experimental cancer therapy shows success in more than 70% of patients in global clinical trials

by The Mount Sinai HospitalCredit: Unsplash/CC0 Public DomainA new therapy that makes the immune system kill bone marrow cancer cells was successful in as many as 73% of patients in two clinical

Updated on: February 18,2024

Experimental cancer therapy shows success in more than 70% of patients in global clinical trials

by The Mount Sinai HospitalCredit: Unsplash/CC0 Public DomainA new therapy that makes the immune system kill bone marrow cancer cells was successful in as many as 73% of patients in two clinical

Updated on:February 18,2024

Scientists discover how the body's killer cells attack cancer

byUniversity of SouthamptonScientists discover how the body's killer cells attack cancer. Credit: University of SouthamptonScientists are on the verge of a cancer breakthrough after working

Updated on: September 07,2024

Scientists discover how the body's killer cells attack cancer

byUniversity of SouthamptonScientists discover how the body's killer cells attack cancer. Credit: University of SouthamptonScientists are on the verge of a cancer breakthrough after working

Updated on:September 07,2024

Research shows PSMA PET/CT imaging changes management for close to 50% of prostate cancer patients

by Society of Nuclear Medicine and Molecular ImagingGraphical Abstract: Patients with detectable PSA (0.2-2.0 ng/mL) post-prostatectomy considered for salvage radiotherapy undergoing18F-DCFPyL P

Updated on: January 22,2024

Research shows PSMA PET/CT imaging changes management for close to 50% of prostate cancer patients

by Society of Nuclear Medicine and Molecular ImagingGraphical Abstract: Patients with detectable PSA (0.2-2.0 ng/mL) post-prostatectomy considered for salvage radiotherapy undergoing18F-DCFPyL P

Updated on:January 22,2024

Lymphoma patients at high risk of infections after diagnosis

byUppsala UniversityGraphical abstract. Credit:HemaSphere(2024). DOI: 10.1002/hem3.121Every year, around 100 people are affected by mantle cell lymphoma. A study at Uppsala Universit

Updated on: July 09,2024

Lymphoma patients at high risk of infections after diagnosis

byUppsala UniversityGraphical abstract. Credit:HemaSphere(2024). DOI: 10.1002/hem3.121Every year, around 100 people are affected by mantle cell lymphoma. A study at Uppsala Universit

Updated on:July 09,2024

Two new studies show how bacteria could help tumors progress and resist treatment

byFred Hutchinson Cancer Research CenterCredit: CC0 Public DomainTwo new studies from researchers at Fred Hutchinson Cancer Center in Seattle reveal how bacteria infiltrate tumors and could be h

Updated on: December 28,2023

Two new studies show how bacteria could help tumors progress and resist treatment

byFred Hutchinson Cancer Research CenterCredit: CC0 Public DomainTwo new studies from researchers at Fred Hutchinson Cancer Center in Seattle reveal how bacteria infiltrate tumors and could be h

Updated on:December 28,2023